When compared with nonusers, tirzepatide was linked to a markedly heightened risk of the composite outcome (HR 1.48), whereas other GLP-1 RAs illustrated no clinically meaningful risk increase (HR 1.07)
Healthcare providers should counsel patients on what to expect during the initiation period, including common side effects and their typical course
Clinical review: glucose control in severely burned patients - current best practice
Why dry mouth shows up on a GLP-1 Cottonmouth is common enough that people assume the drug is drying their saliva, but the usual story is simpler and more fixable: you are mildly dehydrated
Both medications may have similar side effects, risk profiles, and dosing schedules
) Without insurance coverage, patients have to turn elsewhere for these drugs